TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.

Himisha Beltran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.